You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study

 

Online download statistics by month:

Online download statistics by month: April 2023 to January 2026

AbstractFullPdf
Apr 2023581582134
May 2023375378170
Jun 2023240245107
Jul 2023232236102
Aug 202327227495
Sep 202312913462
Oct 202312312458
Nov 202318118163
Dec 20239910061
Jan 202410010065
Feb 202410710751
Mar 2024123127131
Apr 202411811878
May 2024858650
Jun 202410510650
Jul 2024767841
Aug 20248785114
Sep 2024919160
Oct 2024939351
Nov 202412813069
Dec 202412212362
Jan 202510210265
Feb 202520420743
Mar 202511711959
Apr 2025949448
May 2025626340
Jun 2025454527
Jul 2025110
Aug 2025110
Jan 2026001
Total409341301957